(Total Views: 254)
Posted On: 06/18/2018 2:57:46 PM
Post# of 98250
Biotech rocks, $RVXCF in Phase III
Trial for Diabetes patients at high risk of a Major Adverse Cardiac Event slated to end latter this year. FDA and EMA are on board, if Apabetalone drug is approved this could be a blockbuster.
Trial for Diabetes patients at high risk of a Major Adverse Cardiac Event slated to end latter this year. FDA and EMA are on board, if Apabetalone drug is approved this could be a blockbuster.
(0)
(0)
Check out my blog if you like: Avoid The Bag
Scroll down for more posts ▼
